Skip to main content
GB

GT Bio

GT Bio provides an in‑vivo drug delivery atlas that maps therapeutic distribution to individual cell types using spatial transcriptomics, proteomics, and machine‑learning analytics. The cloud‑based platform lets pharma and biotech researchers query, visualize, and download cell‑type‑resolved delivery maps to design and optimize targeted conjugates more quickly and cost‑effectively.

Founded 20242200+ followers
Updated 3 months ago

Funding

Funding not disclosed

Funding rounds are not available yet.

Founders

Founder details are not available yet.

Product

Problem

Developing precision medicines requires detailed knowledge of how therapeutic agents distribute to specific cell types in vivo, but existing methods to generate such delivery data are slow, costly, and often lack the resolution needed for cell‑type targeting.

Solution

GT Bio creates a comprehensive in‑vivo drug delivery atlas that maps the distribution of therapeutics to individual cell populations. By combining spatial biology techniques, targeted conjugate chemistry, and machine‑learning analytics, the platform produces high‑quality delivery data more quickly and at lower cost than traditional approaches. The resulting atlas provides actionable insights for designing cell‑type‑specific delivery systems, enabling the development of precise, scalable, and affordable medicines. Researchers can query the atlas to predict delivery outcomes, optimize conjugate designs, and accelerate preclinical decision‑making.

Target Audience

Primary customers are pharmaceutical and biotech companies developing targeted therapeutics, as well as academic and contract research organizations focused on drug delivery optimization.

Features

  • Integrated spatial transcriptomics and proteomics pipelines to capture cell‑type‑resolved drug localization in animal models
  • Targeted conjugate libraries engineered for selective binding and internalization by defined cell populations
  • Machine‑learning models that analyze spatial data to predict delivery efficiency and off‑target exposure
  • Automated data generation workflow that reduces experimental timelines and per‑sample costs
  • Cloud‑based atlas interface allowing users to search, visualize, and download delivery maps for specific therapeutics and tissues
This profile is AI-generated and may contain inaccuracies.